Gene therapy with RALA/iNOS composite nanoparticles significantly enhances survival in a model of metastatic prostate cancer

Overview of attention for article published in Cancer Nanotechnology, June 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#6 of 169)
High Attention Score compared to outputs of the same age (85th percentile)

Mentioned by

twitter: 19 X users

Citations

dimensions_citation: 30 Dimensions

Readers on

mendeley: 53 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 19 X posts from 19 X users, with an upper bound of 71,721 followers.

RT @CFGT_Edinburgh: There were many great talks at #BSGCT2019 in Sheffield, but @Prof_H_McCarthy's on RALA peptide delivery was outstanding…

22 Jun 2019

Reply Repost Favourite

There were many great talks at #BSGCT2019 in Sheffield, but @Prof_H_McCarthy's on RALA peptide delivery was outstandingly informative & entertaining. Recent application: use of RALA/iNOS to enhance survival in a mouse model of metastatic prostate cance

22 Jun 2019

Reply Repost Favourite

RT @Prof_H_McCarthy: Check out our latest paper validating RALA for in vivo delivery of iNOS DNA in Prostate Cancer - a great collaboration…

17 Jul 2018

Reply Repost Favourite

RT @CancerNanotech: NEW from @CancerNanotech: Gene therapy with RALA/iNOS composite nanoparticles significantly enhances survival in a mode…

23 Jun 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 15 additional X posts.